Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

HBI Spotlight

 

PureHealth’s HHG acquisition signals Middle East’s growing footprint in European healthcare

PureHealth, the Middle East’s largest hospital group by revenue, is acquiring a 60% stake in Greece’s private healthcare giant, Hellenic Healthcare Group (HHG), in a deal valuing HHG at $2.31 billion. Jersey-based private equity firm CVC Capital Partners, which currently owns 90% of HHG, will retain a 35% stake, while HHG’s CEO, Dimitris Spyridis, will keep 5%. The deal is subject to regulatory approvals, after which CVC and HHG management will hold a combined 40% stake and remain strategic partners in the company’s growth.  PureHealth has not disclosed the timeline for completion.
January 31, 2025

Poland’s private healthcare poised for growth as Diagnostyka plans IPO

Diagnostyka, Poland's largest private diagnostic laboratory provider, plans to list on the Warsaw Stock Exchange, hoping to achieve a $1.2 billion valuation. The IPO will involve the sale of shares by private equity firm MidEuropa, which currently backs Diagnostyka, holding a 47.83% stake. Diagnostyka’s founders, key management, and board members will retain their shares, and the company will not issue new ones. A portion of the offering, between 5 - 10%, will be allocated to retail investors, according to a press release.
January 17, 2025

Disruptive technologies and investing in healthcare — Interview with Johannes Virkkunen, European Investment Fund

Healthcare is on the cusp of a digital and AI revolution, with technologies like machine learning and deep learning projected to save $200–$360 billion in the US. With an ageing population and rising demand, healthcare promises growth, making it an attractive space for investors.  This week HBI caught up with Johannes Virkkunen, Head of Life Sciences and Transaction Services Division - Equity Investments at European Investment Fund (EIF), a financial institution for the provision of finance to SMEs headquartered in Luxembourg, about EIF’s investment strategy, underserved sectors and geographies in Europe. Plus, predictions for healthcare investments in 2025 and more. 
December 13, 2024

India has captured the attention of European and global healthcare investors

India, the world's most populous country, has become a hotspot for healthcare investments, seeing some of the industry's largest recent deals. Activity has been particularly strong in three sectors: hospitals, diagnostics, and digital health. A large population, a growing middle class, heightened healthcare awareness, and a shortage of quality healthcare infrastructure in urban and tier 2 and 3 cities have made the country a focal point for global investors who now view it as an "extremely attractive investment destination."
December 6, 2024

UK NHS’ digital transformation “most complex on the planet”

George Murgatroyd, General Manager & Vice President at the Digital Technologies division of Medtronic, the world’s largest medtech company, shared his thoughts with HBI on how far we really need to go to effectively take the NHS from “analogue” to “digital”. Plus, what the role of Medtronic and medtech is in this reform, as demand for tech solutions in healthcare rises. 
November 29, 2024

Finland wants to overhaul primary care, but may struggle to grasp the nettle

Finland’s government has announced a program to introduce a more standard primary care model in which everyone is registered with a local GP, to improve its struggling primary care system. Details of exactly how this will be implemented have yet to be decided, but it looks likely to involve more outsourcing to for-profit providers. But politics could make bold changes to the system difficult.
November 22, 2024

UK IVF sector is set for stronger 2025, with continued PE interest despite growing consolidation

FutureLife Group, a pan-European provider of IVF and genetic services, has announced its expansion in the UK with the acquisition of the independent fertility clinic Bristol Centre for Reproductive Medicine (BCRM). This acquisition strengthens FutureLife’s presence in the UK, complementing its operations at Center for Reproductive and Genetic Health (CRGH) in central London. 
November 15, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us